
The inventory market stays in an uptrend after modest positive factors for the week, which occurred amid indicators that the financial system is slowing down whereas inflation is cooling. It was a interval marked by giant intraday strikes, nonetheless, as traders digested information that Fed officers are anticipating a light recession later this yr. Additionally, knowledge final week confirmed that, whereas inflation is slowing, it stays at a extremely elevated degree, which can result in extra fee hikes.
DAILY CHART OF S&P 500 INDEX
Fed fee hikes within the face of a doable recession isn’t a fantastic backdrop for the markets, and final week’s underperformance within the Know-how sector underscored traders’ concern. These excessive development shares are significantly weak to larger charges and fears of a slowing financial system.
Presently, investing in corporations which might be rising and that additionally fare properly regardless of a possible slowdown within the financial system could be a good way to take part within the present uptrend. Specializing in shares which might be additionally breaking out of a sound base could be excellent, as this chart sample usually precedes additional upside worth motion. Under is a chief instance of a recession-proof firm that broke out of a base final month amid an improved development outlook.
MCDONALD’S CORP. (MCD)
Subscribers to my MEM Edge Report are fairly conversant in McDonald’s (MCD), as we added the inventory to our choose record of Steered Holdings in late March after its base breakout on above-average quantity. MCD’s inexpensive menu, coupled with their working margins bettering greater than Microsoft (MSFT) and different tech corporations, had Wall Road elevating their development outlook for the corporate into year-end. Of be aware, McDonald’s opened virtually 600 new areas throughout the nice recession of 2008, whereas most eating places retreated. The inventory is in a confirmed uptrend with additional upside potential.
Under is Merck (MRK), which broke out of a 3-month base final week amid information that the FDA has accepted their Keytruda-based remedy for superior GI most cancers for evaluation. This information provides to the corporate’s exceptionally deep drug pipeline, which has analysts calling for above-average earnings development over the subsequent 5 years. The two.5% yielder can also be buying and selling at 15 instances trailing 4 quarter earnings, which is under the common P/E for shares within the S&P 500.
DAILY CHART OF MERCK (MRK)
Healthcare shares additionally outperformed throughout 2008 and, whereas we’re not calling for a recession that can be anyplace near what befell again then, priority tells us that revolutionary drug corporations can fare properly regardless of a troublesome financial backdrop. MRK has optimistic momentum, with its RSI and MACD above 50 and headed larger, and final week’s base breakout places the inventory able to commerce larger.
Whereas Know-how shares have underperformed over the previous two weeks, the sector stays in an uptrend with choose areas posting strong positive factors. My MEM Edge Report has a number of top quality Know-how shares on the Steered Holdings Listing which have been outpacing the broader markets and are poised to proceed to take action. We’ll stick with these shares so long as they continue to be in an uptrend.
If you would like fast entry to my Steered Holdings Listing, in addition to be saved on prime of our detailed market and sector rotation evaluation throughout these uneven instances, use this hyperlink for a 4-week trial of my twice weekly MEM Edge Report at a nominal charge.
Warmly,
Mary Ellen McGonagle, MEM Investment Research

Mary Ellen McGonagle is an expert investing advisor and the president of MEM Funding Analysis. After eight years of engaged on Wall Road, Ms. McGonagle left to turn out to be a talented inventory analyst, working with William O’Neill in figuring out wholesome shares with potential to take off. She has labored with purchasers that span the globe, together with massive names like Constancy Asset Administration, Morgan Stanley, Merrill Lynch and Oppenheimer.
Be taught Extra